Post-approval studies (Phase 4)Study completedNCT03782259
What this trial is testing
Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2
Who this might be right for
Type 2 Diabetes MellitusMyocardial FibrosisMyocardial Inflammation
University of Washington 62